•
Sep 30, 2019

Soleno Therapeutics Q3 2019 Earnings Report

EPS
$0.45
Previous year: -$1.65
-127.3%
Cash and Equivalents
$11.2M
Previous year: $10.2M
+9.6%
Free Cash Flow
-$4.72M
Previous year: -$2.68M
+76.0%
Total Assets
$28.7M
Previous year: $30.8M
-6.8%

Soleno Therapeutics

Soleno Therapeutics